ArticleInternational archives of otorhinolaryngology2025
The Awareness of the Jordanian Population Regarding Intranasal Corticosteroids' Uses for Allergic Rhinitis.
Article in International archives of otorhinolaryngology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Intranasal corticosteroids are widely regarded as the most efficacious remedy for managing moderate to severe allergic rhinitis. However, the Jordanian population's understanding and attitudes toward the safe and proper use of these medications remain ambiguous. Objective: This study was undertaken to evaluate Jordanian individuals' awareness of intranasal corticosteroids by examining their present perceptions, attitudes, and behaviors regarding these pharmaceuticals. Methods: We conducted a cross-sectional study within the adult Jordanian demographic using an online survey based on a structured questionnaire. Results: The study comprised 1509 participants, revealing that 34.2% of the adult Jordanian population suffers from allergic rhinitis, with a prevalence of 39.5% in males and 60.5% in females. Among individuals with allergic rhinitis, 34.1%, 38.4%, 67.1%, and 43.2% hold beliefs regarding the impact of intranasal corticosteroids on blood sugar, blood pressure, pregnancy, and obesity, respectively. Notably, 67.8% of allergic rhinitis patients in our study actively use intranasal corticosteroids, and users demonstrate a significantly higher level of awareness compared with non-users, as we found significantly higher awareness levels among allergic rhinitis patients regarding possible side effects compared with non-allergic rhinitis group (p-value = < .0001, 0.0019, 0.0109, <.0001 and 0.0034) for blood sugar, blood pressure, pregnancy, children less than 5 years and obesity respectively. Conclusion: The results obtained from this research underscore the critical need for educational initiatives and interventions to enhance understanding and utilization of these medications within Jordan. These efforts can significantly contribute to improved patient outcomes and decreased healthcare expenses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.